Clinical Research
News & Careers
Search the Site
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login           Employers:  Register | Login   

By Industry | By Industry Segment | By Services and Suppliers | By Location | Profile Search
 Company Profile


AEterna Zentaris 

1405 Boul Du Parc-technologique

Quebec  Quebec  G1P 4P5  Canada
Phone: 418-652-8525 Fax: 418-652-0881


 Company News
AEterna Zentaris (AEZS) Announces Election Of Directors At 2015 Shareholders' Meeting 5/11/2015 4:33:56 PM
AEterna Zentaris (AEZS) Reports 1st Quarter 2015 Financial And Operating Results 5/8/2015 10:17:22 AM
AEterna Zentaris (AEZS) And EMD Serono Finalize Promotional Services Agreement For Saizen (Somatropin (rDNA origin) For Injection) In The U.S. 5/7/2015 7:31:39 AM
ErgoMed’s Co-Development Partner AEterna Zentaris (AEZS) Obtains Positive Recommendation From Data Safety Monitoring Board 4/29/2015 8:53:27 AM
AEterna Zentaris (AEZS): Data Safety Monitoring Board Recommends Continuation Of Phase 3 Study Of Zoptarelin Doxorubicin In Advanced Endometrial Cancer 4/28/2015 9:38:45 AM
Crystal Research Associates, LLC Issues Executive Informational Overview (EIO) On AEterna Zentaris (AEZS) 4/24/2015 12:08:55 PM
AEterna Zentaris (AEZS) Files Additional Patent Application To Strengthen IP Protection Of Zoptarelin Doxorubicin 4/16/2015 6:40:18 AM
AEterna Zentaris (AEZS) Announces Plans To Initiate Phase 3 Study Of Macrilen In AGHD Following Successful Meeting With FDA 4/13/2015 6:19:18 AM
AEterna Zentaris (AEZS) Signs Transfer Agreement Of Its Discovery Library With The Medical University of South Carolina 3/31/2015 6:08:42 AM
AEterna Zentaris (AEZS) Reports Fourth Quarter And Full-Year 2014 Financial And Operating Results 3/18/2015 7:56:16 AM